
New HIV-Vaccine Tested on People Shows Limited Success
Scientists have tested a new
'therapeutic vaccine'
against HIV on volunteers.
The participants were 'so to
say' vaccinated with their
own cells. The immune system
... > full story

New Way to Learn About -- And Potentially Block -- Traits in Harmful Pathogens
Researchers have developed a
new way to identify the
genes of harmful microbes,
particularly those that have
been difficult to study in
... > full story

Pathogenic Landscape of HIV: Hundreds of Connections Between Viral and Human Proteins Identified in Work That May Reveal New Drug Targets
In perhaps the most
comprehensive survey of the
inner workings of HIV, an
international team of
scientists led by
... > full story

Skeletons Point to Columbus Voyage for Syphilis Origins
Skeletal evidence that
reputedly showed signs of
syphilis in Europe and other
parts of the Old World
before Christopher Columbus
made his voyage in 1492 does
... > full story
- New HIV-Vaccine Tested on People Shows Limited Success
- New Way to Learn About -- And Potentially Block -- Traits in Harmful Pathogens
- Pathogenic Landscape of HIV: Hundreds of Connections Between Viral and Human Proteins Identified in Work That May Reveal New Drug Targets
- Skeletons Point to Columbus Voyage for Syphilis Origins
Stay up to date!
Get all of ScienceDaily's STD headlines automatically delivered to you every day by subscribing for free via:
Browse News Stories
1 to 10 of 1,326 stories (138 over past year)
view headlines only
-
Scientist Works to Detach Protein That HIV Uses as Protective Shield
February 13, 2012 One of the frustrations for scientists working on HIV/AIDS treatments has been the human immunodeficiency virus' ability to evade the body's immune system. Now a researcher has discovered a compound ... > full story -
Starve a Virus, Feed a Cure?
February 12, 2012 A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate. While ... > full story -
How a Protein Protects Cells from HIV Infection
February 12, 2012 A novel discovery reveals a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the ... > full story -
A Lonely Heart Can Make You Sick: Middle Aged Divorced Women Vulnerable to Contracting HIV
February 3, 2012 Newly divorced middle aged women are more vulnerable to contract HIV and other sexually transmitted diseases, according to new research, because they tend to let their guard down with new sexual ... > full story -
Drug to Treat HIV in Children Shows Promise Via National Clinical Trial
January 6, 2012 For children with HIV infection, the FDA approval of the use of raltegravir, an antiretroviral drug that slows the spread of HIV infection, offers a new weapon to treat HIV infection in ... > full story -
Progress Made Toward a Genital Herpes Vaccine
January 4, 2012 New research points investigators toward finding a genital herpes vaccine that works on both viruses that cause ... > full story -
Guidelines Stress Caution When Combining Anti-Epileptic, HIV Drugs
January 4, 2012 New guidelines will help physicians better choose seizure drugs for people on HIV/AIDS medication, avoiding deadly drug interactions and preventing critical anti-HIV drugs from becoming less ... > full story -
Experimental Vaccine Partially Protects Monkeys from HIV-Like Infection
January 4, 2012 New vaccine research in monkeys suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical ... > full story -
Females May Be More Susceptible to Infection During Ovulation
January 3, 2012 A woman's ovarian cycle plays a role in susceptibility to infection, according to new research. Specifically, researchers found women are most susceptible to infection, such as Candida albicans or ... > full story -
HIV Study Named '2011 Breakthrough of the Year' by Science
December 23, 2011 The journal Science has chosen the HPTN 052 clinical trial, an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National ... > full story
Recommend this page on Facebook, Twitter,
and Google +1:
Other bookmarking and sharing tools:
Search ScienceDaily
Number of stories in archives: 115,005

